Concepedia

Ashley Alarcon Rozas

AA

Statistics

Publications

2

Citations

50

H-Index

2

Active since

2012

Affiliations

Boehringer Ingelheim (Germany)(Current)

Baylor College of Medicine

Hospital Moinhos de Vento

Boehringer Ingelheim (Brazil)

Ashley Alarcon Rozas is an author at Boehringer Ingelheim (Germany) specializing in breast cancer, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

2012–2014

2

Publications

2

A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer

Mothaffar F. Rimawi, Sabina B. Aleixo, Ashley Alarcon Rozas et al. · Clinical Breast Cancer · 2014 · 40 citations

, , +4

A neoadjuvant, randomized, open-label phase II trial of afatinib (A) versus trastuzumab (T) versus lapatinib (L) in patients (pts) with locally advanced HER2-positive breast cancer (BC).

Mothaffar F. Rimawi, Sabina B. Aleixo, Ashley Alarcon Rozas et al. · Journal of Clinical Oncology · 2012 · 10 citations

, , +14

1–2 of 2